Search results
Results from the WOW.Com Content Network
Additionally, NIAID partnerships with industry and academia have led to the advancement of diagnostic tests for several important infectious diseases, including malaria (ParaSight F), tuberculosis (GeneXpert MTB/RIF), and norovirus (Ridascreen Norovirus 3rd Generation EIA). NIAID has done research on mother-to-child transmission (MTCT) of HIV.
The NIH frequently uses commercial images which are not public domain. This file has been identified as being free of known restrictions under copyright law, including all related and neighboring rights.
cAd3-ZEBOV (also known as the NIAID/GSK Ebola vaccine or cAd3-EBO Z) was an experimental vaccine for two ebolaviruses, Ebola virus and Sudan virus, developed by scientists at GlaxoSmithKline (GSK) and tested by National Institute of Allergy and Infectious Disease (NIAID). [1]
Eli Lilly and Company (NYSE: LLY) said Monday that a trial of its antibody treatment for use in hospitalized COVID-19 patients has come to an end as the treatment is unlikely to help such patients.
If you've been having trouble with any of the connections or words in Saturday's puzzle, you're not alone and these hints should definitely help you out. Plus, I'll reveal the answers further down ...
Adding to the mystery was last week’s arrest of a registered sex offender who claimed he stumbled on the body three days before Christmas — then allegedly refused to hand over his cell phone ...
Logo of the United States National Institute of Allergy and Infectious Diseases , part of the National Institutes of Health. The logo is a stylized representation of an antibody, a protein made by the body’s immune system cells to protect it against invading foreign substances. For more information, see here and here. Source
Hugh Auchincloss, Jr. (/ ˈ ɔː k ɪ n k l ɒ s / AW-kin-kloss; born March 15, 1949) is an American immunologist and physician who served as the acting director of the National Institute of Allergy and Infectious Diseases from January to August 2023. Previously, he was the principal deputy director of the NIAID, from 2006 to 2022.